Venbio Global Strategic Gp Iii, Ltd - Net Worth and Insider Trading

Venbio Global Strategic Gp Iii, Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Venbio Global Strategic Gp Iii, Ltd owns 3 companies in total, including Elevation Oncology Inc (ELEV) , Ventyx Biosciences Inc (VTYX) , and RayzeBio inc (RYZB) .

Click here to see the complete history of Venbio Global Strategic Gp Iii, Ltd’s form 4 insider trades.

Insider Ownership Summary of Venbio Global Strategic Gp Iii, Ltd

Ticker	Comapny	Transaction Date	Type of Owner
ELEV	Elevation Oncology Inc	2021-06-24	10 percent owner
VTYX	Ventyx Biosciences Inc	2021-10-20	10 percent owner & other: See Remarks
RYZB	RayzeBio inc	2023-09-14	10 percent owner

Venbio Global Strategic Gp Iii, Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Venbio Global Strategic Gp Iii, Ltd Ownership Network

Ownership Network List of Venbio Global Strategic Gp Iii, Ltd

No Data

Ownership Network Relation of Venbio Global Strategic Gp Iii, Ltd

Venbio Global Strategic Gp Iii, Ltd Owned Company Details

What does Elevation Oncology Inc do?

Who are the key executives at Elevation Oncology Inc?

Venbio Global Strategic Gp Iii, Ltd is the 10 percent owner of Elevation Oncology Inc. Other key executives at Elevation Oncology Inc include CHIEF FINANCIAL OFFICER Tammy Furlong , 10 percent owner Robert J Adelman , and 10 percent owner Venbio Global Strategic Gp Iii, L.p. .

Elevation Oncology Inc (ELEV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elevation Oncology Inc Insider Transactions

No Available Data

What does Ventyx Biosciences Inc do?

Who are the key executives at Ventyx Biosciences Inc?

Venbio Global Strategic Gp Iii, Ltd is the 10 percent owner & other: See Remarks of Ventyx Biosciences Inc. Other key executives at Ventyx Biosciences Inc include director & Chief Executive Officer Raju Mohan , Chief Financial Officer Martin Auster , and Chief Scientific Officer John Nuss .

Ventyx Biosciences Inc (VTYX) Insider Trades Summary

Over the past 18 months, Venbio Global Strategic Gp Iii, Ltd made no insider transaction in Ventyx Biosciences Inc (VTYX). Other recent insider transactions involving Ventyx Biosciences Inc (VTYX) include a net sale of 1,073,232 shares made by Nsv Partners Iii Lp , a net sale of 1,073,232 shares made by Somu Subramaniam , and a net sale of 328,526 shares made by Raju Mohan .

In summary, during the past 3 months, insiders sold 9,019 shares of Ventyx Biosciences Inc (VTYX) in total and bought 0 shares, with a net sale of 9,019 shares. During the past 18 months, 3,186,455 shares of Ventyx Biosciences Inc (VTYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,186,455 shares.

Ventyx Biosciences Inc (VTYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ventyx Biosciences Inc Insider Transactions

No Available Data

What does RayzeBio inc do?

Who are the key executives at RayzeBio inc?

Venbio Global Strategic Gp Iii, Ltd is the 10 percent owner of RayzeBio inc. Other key executives at RayzeBio inc include 10 percent owner Viking Global Investors Lp , 10 percent owner Viking Global Opportunities Drawdown (aggregator) Lp , and 10 percent owner Goodman Corey S .

RayzeBio inc (RYZB) Insider Trades Summary

Over the past 18 months, Venbio Global Strategic Gp Iii, Ltd made no insider transaction in RayzeBio inc (RYZB). Other recent insider transactions involving RayzeBio inc (RYZB) include a net purchase of 2,777,778 shares made by Viking Global Investors Lp , and a net purchase of 472,222 shares made by Maha Katabi .

In summary, during the past 3 months, insiders sold 0 shares of RayzeBio inc (RYZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RayzeBio inc (RYZB) were sold and 3,250,000 shares were bought by its insiders, resulting in a net purchase of 3,250,000 shares.

RayzeBio inc (RYZB)'s detailed insider trading history can be found in Insider Trading Tracker table.

RayzeBio inc Insider Transactions

No Available Data

Venbio Global Strategic Gp Iii, Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Venbio Global Strategic Gp Iii, Ltd. You might contact Venbio Global Strategic Gp Iii, Ltd via mailing address: 1700 Owens Street, Suite 595, San Francisci Ca 94158.

Discussions on Venbio Global Strategic Gp Iii, Ltd

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.